United States Biotechnology & Medical Research

Verona Pharma PLC (VRNA)

Track

Ticker: VRNA Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Verona Pharma PLC. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 1 Aug 2025
Value US$2,240,007.80 | Price 204.55 | Shares 21,007 (+42.2%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-08-05 2025-08-01 S Sale
Cunningham Kenneth
Non-Executive Director
21,007 +42.2%
204.55
US$2,240,008 		21,007 +42.2% 204.55 US$2,240,008
2025-08-05 2025-08-01 S Sale
Deschamps Lisa
Non-Executive Director
14,069 -6.1%
76.04
US$4,229,502 		14,069 -6.1% 76.04 US$4,229,502
2025-08-05 2025-08-01 S Sale
3.4
Fisher Andrew

General Counsel

Officer
8,595 +12.5%
116.71
US$2,410,077 		8,595 +12.5% 116.71 US$2,410,077
2025-08-05 2025-08-01 PlS Planned sale
Rickard Kathleen A.

Chief Medical Officer

Officer
58,336 -2.2%
13.14
US$766,751 		58,336 -2.2% 13.14 US$766,751
2025-08-05 2025-08-01 S Sale
EBSWORTH DAVID R
Non-Executive Director
1,904 -0.2%
13.14
US$25,026 		1,904 -0.2% 13.14 US$25,026
2025-08-05 2025-08-01 S Sale
2.2
ACKERMANN CHRISTINA
Non-Executive Director
1,808 -2.7%
13.14
US$23,764 		1,808 -2.7% 13.14 US$23,764
2025-08-05 2025-08-01 PlS Planned sale
ZACCARDELLI DAVID

President and CEO

Executive Director
208,912 -1.5%
13.14
US$2,745,877 		208,912 -1.5% 13.14 US$2,745,877
2025-08-05 2025-08-01 PlS Planned sale
Hahn Mark W

Chief Financial Officer

Officer
208,912 -1.6%
13.14
US$2,745,877 		208,912 -1.6% 13.14 US$2,745,877
2025-08-05 2025-08-01 S Sale
Austwick Michael
Non-Executive Director
11,288 -47.0%
13.14
US$148,366 		11,288 -47.0% 13.14 US$148,366
2025-08-05 2025-08-01 S Sale
Brady James Aloysius
Non-Executive Director
824 -3.4%
13.14
US$10,830 		824 -3.4% 13.14 US$10,830
2025-08-05 2025-08-01 S Sale
3.4
Edwards Martin
Non-Executive Director
10,808 -6.4%
13.14
US$142,057 		10,808 -6.4% 13.14 US$142,057
2025-08-05 2025-08-01 S Sale
SHAH MAHENDRA
Non-Executive Director
3,608 -3.7%
13.14
US$47,422 		3,608 -3.7% 13.14 US$47,422
2025-08-05 2025-08-01 S Sale
2.7
Sinha Vikas
Non-Executive Director
4,328 -4.4%
13.14
US$56,886 		4,328 -4.4% 13.14 US$56,886
2025-06-18 2025-06-16 PlS Planned sale
3.4
Fisher Andrew

General Counsel

Officer
80,000 -18.2%
11.53
US$922,000 		80,000 -18.2% 11.53 US$922,000
2025-06-13 2025-06-11 PlS Planned sale
ZACCARDELLI DAVID

President and CEO

Executive Director
400,000 -2.9%
11.40
US$4,560,520 		400,000 -2.9% 11.40 US$4,560,520
2025-06-13 2025-06-11 PlS Planned sale
Hahn Mark W

Chief Financial Officer

Officer
400,000 -3.2%
11.40
US$4,560,360 		400,000 -3.2% 11.40 US$4,560,360
2025-06-11 2025-06-11 PrS Proposed sale
DAVID ZACCARDELLI

Director; Officer

Executive Director
50,000
86.78
US$4,339,000 		50,000 86.78 US$4,339,000
2025-06-11 2025-06-11 PrS Proposed sale
MARK HAHN

Officer

Officer
50,000
86.78
US$4,339,000 		50,000 86.78 US$4,339,000
2025-05-29 2025-05-29 PlS Planned sale
Hahn Mark W

Chief Financial Officer

Officer
204,864 -1.6%
9.33
US$1,911,668 		204,864 -1.6% 9.33 US$1,911,668
2025-05-29 2025-05-29 PlS Planned sale
ZACCARDELLI DAVID

President and CEO

Executive Director
208,696 -1.5%
9.33
US$1,947,593 		208,696 -1.5% 9.33 US$1,947,593
2025-05-29 2025-05-28 PlS Planned sale
Hahn Mark W

Chief Financial Officer

Officer
162,704 -1.2%
9.30
US$1,513,294 		162,704 -1.2% 9.30 US$1,513,294
2025-05-29 2025-05-28 PlS Planned sale
ZACCARDELLI DAVID

President and CEO

Executive Director
157,704 -1.1%
9.30
US$1,466,805 		157,704 -1.1% 9.30 US$1,466,805
2025-05-29 2025-05-27 PlS Planned sale
Hahn Mark W

Chief Financial Officer

Officer
32,432 -0.2%
9.53
US$308,983 		32,432 -0.2% 9.53 US$308,983
2025-05-29 2025-05-27 PlS Planned sale
ZACCARDELLI DAVID

President and CEO

Executive Director
33,600 -0.2%
9.53
US$320,181 		33,600 -0.2% 9.53 US$320,181
2025-05-27 2025-05-27 PrS Proposed sale
DAVID ZACCARDELLI

Director; Officer

Executive Director
50,000
75.06
US$3,753,000 		50,000 75.06 US$3,753,000
2025-05-27 2025-05-27 PrS Proposed sale
MARK HAHN

Officer

Officer
50,000
75.06
US$3,753,000 		50,000 75.06 US$3,753,000
2025-05-22 2025-05-20 PlS Planned sale
2.7
Sinha Vikas
Non-Executive Director
160,000 -68.2%
9.39
US$1,502,928 		160,000 -68.2% 9.39 US$1,502,928
2025-05-20 2025-05-20 PrS Proposed sale
2.7
VIKAS SINHA

Director

Non-Executive Director
20,000
72.58
US$1,451,600 		20,000 72.58 US$1,451,600
2025-05-16 2025-05-15 PlS Planned sale
3.4
Fisher Andrew

General Counsel

Officer
80,000 -18.2%
8.57
US$685,600 		80,000 -18.2% 8.57 US$685,600
2025-05-15 2025-05-15 PrS Proposed sale
3.4
ANDREW FISHER

Officer

Officer
30,000
67.24
US$2,017,200 		30,000 67.24 US$2,017,200
2025-05-16 2025-05-14 PlS Planned sale
2.2
ACKERMANN CHRISTINA
Non-Executive Director
40,000 -48.9%
8.44
US$337,600 		40,000 -48.9% 8.44 US$337,600
2025-05-14 2025-05-14 PrS Proposed sale
2.2
CHRISTINA ACKERMANN

Director

Non-Executive Director
5,000
67.57
US$337,850 		5,000 67.57 US$337,850
2025-05-08 2025-05-06 PlS Planned sale
Rickard Kathleen A.

Chief Medical Officer

Officer
114,984 -4.3%
8.82
US$1,014,343 		114,984 -4.3% 8.82 US$1,014,343
2025-05-06 2025-05-06 PrS Proposed sale
KATHLEEN RICKARD

Officer

Officer
14,373
72.25
US$1,038,449 		14,373 72.25 US$1,038,449
2025-05-05 2025-05-02 PlS Planned sale
Hahn Mark W

Chief Financial Officer

Officer
400,000 -3.0%
9.09
US$3,637,720 		400,000 -3.0% 9.09 US$3,637,720
2025-05-05 2025-05-02 PlS Planned sale
ZACCARDELLI DAVID

President and CEO

Executive Director
400,000 -2.8%
9.09
US$3,637,520 		400,000 -2.8% 9.09 US$3,637,520
2025-05-02 2025-05-02 PrS Proposed sale
MARK HAHN

Officer

Officer
50,000
72.26
US$3,613,000 		50,000 72.26 US$3,613,000
2025-05-02 2025-05-02 PrS Proposed sale
DAVID ZACCARDELLI

Director; Officer

Executive Director
50,000
72.26
US$3,613,000 		50,000 72.26 US$3,613,000
2025-05-05 2025-05-01 PlS Planned sale
Hahn Mark W

Chief Financial Officer

Officer
78,736 -0.6%
8.95
US$704,703 		78,736 -0.6% 8.95 US$704,703
2025-05-05 2025-05-01 PlS Planned sale
Hahn Mark W

Chief Financial Officer

Officer
108,272 -0.8%
8.95
US$969,056 		108,272 -0.8% 8.95 US$969,056
2025-05-05 2025-05-01 PlS Planned sale
Rickard Kathleen A.

Chief Medical Officer

Officer
21,864 -0.8%
8.95
US$195,687 		21,864 -0.8% 8.95 US$195,687
2025-05-05 2025-05-01 PlS Planned sale
Rickard Kathleen A.

Chief Medical Officer

Officer
27,336 -1.0%
8.95
US$244,663 		27,336 -1.0% 8.95 US$244,663
2025-05-05 2025-05-01 PlS Planned sale
ZACCARDELLI DAVID

President and CEO

Executive Director
78,736 -0.5%
8.95
US$704,703 		78,736 -0.5% 8.95 US$704,703
2025-05-05 2025-05-01 PlS Planned sale
ZACCARDELLI DAVID

President and CEO

Executive Director
108,272 -0.8%
8.95
US$969,056 		108,272 -0.8% 8.95 US$969,056
2025-05-01 2025-04-29 PlS Planned sale
2.7
Sinha Vikas
Non-Executive Director
4,952 -6.2%
8.92
US$44,176 		4,952 -6.2% 8.92 US$44,176
2025-05-01 2025-04-29 PlS Planned sale
2.7
Sinha Vikas
Non-Executive Director
15,048 -16.8%
8.92
US$134,240 		15,048 -16.8% 8.92 US$134,240
2025-05-01 2025-04-29 PlS Planned sale
Hahn Mark W

Chief Financial Officer

Officer
90,360 -0.7%
8.98
US$811,433 		90,360 -0.7% 8.98 US$811,433
2025-05-01 2025-04-29 PlS Planned sale
Rickard Kathleen A.

Chief Medical Officer

Officer
34,384 -1.3%
8.98
US$308,768 		34,384 -1.3% 8.98 US$308,768
2025-05-01 2025-04-29 PlS Planned sale
ZACCARDELLI DAVID

President and CEO

Executive Director
90,360 -0.6%
8.98
US$811,433 		90,360 -0.6% 8.98 US$811,433
2025-05-01 2025-04-29 S Sale
3.4
Fisher Andrew

General Counsel

Officer
26,072 -6.8%
8.98
US$234,127 		26,072 -6.8% 8.98 US$234,127
2025-04-29 2025-04-29 PrS Proposed sale
2.7
VIKAS SINHA

Director

Non-Executive Director
20,000
68.83
US$1,376,600 		20,000 68.83 US$1,376,600
2025-03-13 2025-03-12 PlS Planned sale
Rickard Kathleen A.

Chief Medical Officer

Officer
79,264 -2.9%
8.35
US$661,942 		79,264 -2.9% 8.35 US$661,942
2025-03-12 2025-03-12 PrS Proposed sale
KATHLEEN RICKARD

Officer

Officer
9,908
62.70
US$621,232 		9,908 62.70 US$621,232
2024-12-06 2024-12-06 PlS Planned sale
Hahn Mark W

Chief Financial Officer

Officer
183,728 -1.4%
5.01
US$920,312 		183,728 -1.4% 5.01 US$920,312
2024-12-06 2024-12-06 PlS Planned sale
ZACCARDELLI DAVID

President and CEO

Executive Director
162,800 -1.1%
5.01
US$815,400 		162,800 -1.1% 5.01 US$815,400
2024-12-06 2024-12-05 PlS Planned sale
Hahn Mark W

Chief Financial Officer

Officer
640,048 -4.5%
5.01
US$3,204,144 		640,048 -4.5% 5.01 US$3,204,144
2024-12-06 2024-12-05 PlS Planned sale
ZACCARDELLI DAVID

President and CEO

Executive Director
640,264 -4.3%
5.01
US$3,205,226 		640,264 -4.3% 5.01 US$3,205,226
2024-12-06 2024-12-04 PlS Planned sale
Hahn Mark W

Chief Financial Officer

Officer
58,184 -0.4%
5.00
US$290,996 		58,184 -0.4% 5.00 US$290,996
2024-12-06 2024-12-04 PlS Planned sale
ZACCARDELLI DAVID

President and CEO

Executive Director
67,608 -0.4%
5.00
US$338,162 		67,608 -0.4% 5.00 US$338,162
2024-12-02 2024-12-02 PlS Planned sale
Hahn Mark W

Chief Financial Officer

Officer
1,600 -0.0%
5.00
US$8,000 		1,600 -0.0% 5.00 US$8,000
2024-12-02 2024-12-02 PlS Planned sale
ZACCARDELLI DAVID

President and CEO

Executive Director
3,200 -0.0%
5.00
US$16,000 		3,200 -0.0% 5.00 US$16,000
2024-12-02 2024-11-29 PlS Planned sale
Hahn Mark W

Chief Financial Officer

Officer
98,704 -0.7%
5.01
US$494,142 		98,704 -0.7% 5.01 US$494,142
2024-12-02 2024-11-29 PlS Planned sale
ZACCARDELLI DAVID

President and CEO

Executive Director
98,888 -0.7%
5.01
US$495,033 		98,888 -0.7% 5.01 US$495,033
2024-12-02 2024-11-27 PlS Planned sale
Hahn Mark W

Chief Financial Officer

Officer
12,936 -0.1%
5.00
US$64,680 		12,936 -0.1% 5.00 US$64,680
2024-12-02 2024-11-27 PlS Planned sale
ZACCARDELLI DAVID

President and CEO

Executive Director
23,240 -0.2%
5.00
US$116,200 		23,240 -0.2% 5.00 US$116,200
2024-11-26 2024-11-26 PlS Planned sale
Hahn Mark W

Chief Financial Officer

Officer
800 -0.0%
5.00
US$4,000 		800 -0.0% 5.00 US$4,000
2024-11-26 2024-11-25 PlS Planned sale
ZACCARDELLI DAVID

President and CEO

Executive Director
1,600 -0.0%
5.00
US$8,000 		1,600 -0.0% 5.00 US$8,000
2024-11-26 2024-11-25 PlS Planned sale
Hahn Mark W

Chief Financial Officer

Officer
1,600 -0.0%
5.00
US$8,000 		1,600 -0.0% 5.00 US$8,000
2024-11-26 2024-11-25 PlS Planned sale
Rickard Kathleen A.

Chief Medical Officer

Officer
240,000 -8.2%
4.90
US$1,176,360 		240,000 -8.2% 4.90 US$1,176,360
2024-11-25 2024-11-25 PrS Proposed sale
KATHLEEN A RICKARD

Officer

Officer
30,000
39.21
US$1,176,357 		30,000 39.21 US$1,176,357
2024-11-18 2024-11-18 B Purchase
EBSWORTH DAVID R
Non-Executive Director
20,000 +2.2%
4.44
US$88,800 		20,000 +2.2% 4.44 US$88,800
2024-11-13 2024-11-11 PlS Planned sale
Hahn Mark W

Chief Financial Officer

Officer
2,400 -0.0%
5.00
US$12,000 		2,400 -0.0% 5.00 US$12,000
2024-11-13 2024-11-11 PlS Planned sale
ZACCARDELLI DAVID

President and CEO

Executive Director
2,400 -0.0%
5.00
US$12,000 		2,400 -0.0% 5.00 US$12,000
2024-11-12 2024-11-11 PrS Proposed sale
MARK HAHN

Officer

Officer
125,000
38.58
US$4,822,500 		125,000 38.58 US$4,822,500
2024-11-12 2024-11-11 PrS Proposed sale
DAVID ZACCARDELLI

Director; Officer

Executive Director
125,000
38.58
US$4,822,500 		125,000 38.58 US$4,822,500
Explore more

More insider trading research around Verona Pharma PLC

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America